March-April 2024
Interventions and Assessments
- Acamprosate and Oral Naltrexone Are Effective—but Underutilized—Medications for Alcohol Use Disorder
- State of the Evidence for Psychosocial Interventions Among People With Alcohol Use Disorder and Liver Disease
- Real-world Administration of Extended-release Buprenorphine Suggests That Deviation From Standard Dosing is Common
- Bupropion Modestly Effective for Amphetamine-type Stimulant Use Disorder
Health Outcomes
- Buprenorphine Interrupted or Discontinued Among a Majority of Inpatients in Veterans Administration Hospitals
- Establishment of an Overdose Prevention Site Was Not Associated With an Increase in Visible Signs of Substance Use and Homelessness